Galway's Crospon secures FDA approval for reflux-testing tool

Galway-based medical device developer Crospon has received approval form the US Food and Drugs Administration (FDA) for its diagnostic test for gastroesophageal reflux disease EndoFLIP.

Galway's Crospon secures FDA approval for reflux-testing tool

Galway-based medical device developer Crospon has received approval form the US Food and Drugs Administration (FDA) for its diagnostic test for gastroesophageal reflux disease EndoFLIP.

The company is now free to sell EndoFLIP in the US.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited